These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 27422418)

  • 1. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects.
    Ray JG; Ranganathan K; Chattopadhyay A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.
    Chattopadhyay A; Ray JG
    J Environ Pathol Toxicol Oncol; 2016; 35(3):193-205. PubMed ID: 27910776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral submucous fibrosis: review on mechanisms of malignant transformation.
    Ekanayaka RP; Tilakaratne WM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):192-9. PubMed ID: 27289264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
    Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
    J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
    Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
    Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
    J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral submucous fibrosis. The South African experience.
    VanWyk CW
    Indian J Dent Res; 1997; 8(2):39-45. PubMed ID: 9495135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically malignant exophytic lesions in the background of oral submucous fibrosis: report of five cases.
    Jayasinghe LA; Peiris PM; Tilakaratne WM; Attygalla AM; Jayasinghe RD; Sitheeque MA; Siriwardena BS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):210-5. PubMed ID: 27422419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.
    Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X
    Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a combined biomarker for malignant transformation in oral submucous fibrosis.
    Bazarsad S; Zhang X; Kim KY; Illeperuma R; Jayasinghe RD; Tilakaratne WM; Kim J
    J Oral Pathol Med; 2017 Jul; 46(6):431-438. PubMed ID: 27497264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China.
    Liu B; Shen M; Xiong J; Yuan Y; Wu X; Gao X; Xu J; Guo F; Jian X
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):337-45. PubMed ID: 26130067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
    Auluck A; Rosin MP; Zhang L; Sumanth KN
    J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral submucous fibrosis. A review.
    Cox SC; Walker DM
    Aust Dent J; 1996 Oct; 41(5):294-9. PubMed ID: 8961601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.
    Mohiuddin S; Fatima N; Hosein S; Fatima N
    J Pak Med Assoc; 2016 Nov; 66(11):1362-1366. PubMed ID: 27812049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of CYP1A1 and CYP2E1 Gene Polymorphisms in Oral Submucous Fibrosis.
    Yaming P; Urs AB; Saxena A; Zuberi M
    Asian Pac J Cancer Prev; 2016; 17(7):3335-40. PubMed ID: 27509973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
    Phulari RGS; Dave EJ
    Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis.
    Cirillo N; Duong PH; Er WT; Do CTN; De Silva MEH; Dong Y; Cheong SC; Sari EF; McCullough MJ; Zhang P; Prime SS
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral submucous fibrosis: An enigmatic morpho-insight.
    Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
    J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China.
    Tang JG; Jian XF; Gao ML; Ling TY; Zhang KH
    Community Dent Oral Epidemiol; 1997 Apr; 25(2):177-80. PubMed ID: 9181294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.